| Fonds | 2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | |
| 4.465.307 $ | +1.136.050 $ | +34,1 % | 70.644.670 $ | +9.386.450 $ | +15,3 % | 62.206.400 $ | -4.969.889 $ | -5,8 % | 77.959.441 $ | +13.904.683 $ | +20,7 % | |
| RA CAPITAL MANAGEMENT, L.P. | 22.798.822 $ | +2.809.333 $ | +14,1 % | 19.989.489 $ | -2.377.128 $ | -10,6 % | 22.366.617 $ | +4.430.103 $ | +24,7 % | |||
| TANG CAPITAL MANAGEMENT LLC | 14.605.042 $ | +2.892.786 $ | +24,7 % | |||||||||
| BlackRock, Inc. | 9.512.878 $ | +1.899.872 $ | +25,0 % | 7.613.006 $ | -42.965 $ | -0,6 % | 7.655.971 $ | +760.589 $ | +11,0 % | |||
| Samsara BioCapital, LLC | 7.401.175 $ | +911.993 $ | +14,1 % | 6.489.182 $ | -1.310.650 $ | -16,8 % | 7.799.832 $ | +1.544.894 $ | +24,7 % | |||
| NEA Management Company, LLC | 7.530.128 $ | +927.883 $ | +14,1 % | 6.602.245 $ | -785.132 $ | -10,6 % | 7.387.377 $ | +1.463.201 $ | +24,7 % | |||
| SR ONE CAPITAL MANAGEMENT, LP | 7.033.333 $ | +866.667 $ | +14,1 % | 6.166.666 $ | -733.333 $ | -10,6 % | 6.899.999 $ | +1.366.666 $ | +24,7 % | |||
| GSK plc | 6.648.045 $ | +819.191 $ | +14,1 % | 5.828.854 $ | ||||||||
| CITADEL ADVISORS LLC | 6.086.748 $ | +528.697 $ | +9,5 % | |||||||||
| Monaco Asset Management SAM | 5.321.277 $ | +609.453 $ | +12,9 % | 4.711.824 $ | +632.040 $ | +15,5 % | ||||||
| VANGUARD GROUP INC | 4.805.134 $ | -352.721 $ | -6,8 % | 5.157.855 $ | +917.747 $ | +21,6 % | ||||||
| WASATCH ADVISORS LP | 4.465.307 $ | +1.136.050 $ | +34,1 % | |||||||||
| Alyeska Investment Group, L.P. | 4.399.012 $ | +542.058 $ | +14,1 % | |||||||||
| 4.465.307 $ | +1.136.050 $ | +34,1 % | 70.644.670 $ | +9.386.450 $ | +15,3 % | 62.206.400 $ | -4.969.889 $ | -5,8 % | 77.959.441 $ | +13.904.683 $ | +20,7 % | |